---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-073501"
form_type: "8-K"
ticker: "BOLT"
cik: "0001641281"
company_name: "Bolt Biotherapeutics, Inc."
filed_at: "2024-06-14T23:59:59+00:00"
generated_at: "2026-06-01T04:20:22.920216+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Bolt Biotherapeutics annual meeting elects directors and ratifies auditor

## Summary
- Director Kathleen LaPorte elected with 12,706,287 votes for, 3,990,176 withheld, 9,231,722 broker non-votes.
- Director Nicole Onetto elected with 12,819,050 votes for, 3,880,294 withheld, 9,228,841 broker non-votes.
- Ratification of PricewaterhouseCoopers LLP as auditor for FY2024: 23,736,566 for, 2,032,686 against, 158,933 abstaining.
- Total shares represented at meeting: 25,928,185 of 38,127,740 shares entitled.

## SEC filing metadata
- accession: 0000950170-24-073501
- form_type: 8-K
- ticker: BOLT
- cik: 0001641281
- company_name: Bolt Biotherapeutics, Inc.
- filed_at: 2024-06-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641281/000095017024073501/0000950170-24-073501-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641281/000095017024073501/bolt-20240612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-073501
- JSON: https://secwatch.observer/filing/0000950170-24-073501.json
- Plain text: https://secwatch.observer/filing/0000950170-24-073501.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.